English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2707]
News [7043]
Articles [266]
Editorials [8]
Conferences [213]
elearning [41]
New immunotherapy technique can specifically target tumour cells, UCI study reports
New immunotherapy technique can specifically target tumour cells, UCI study reports
Campaigners call for stronger rights to work for people living with breast cancer
Campaigners call for stronger rights to work for people living with breast cancer
Dana-Farber scientists find new drug targets in aggressive cancers
Dana-Farber scientists find new drug targets in aggressive cancers
Doctors and nurses reluctant to recommend e-cigarettes to cancer patients
Doctors and nurses reluctant to recommend e-cigarettes to cancer patients
RNA defects linked to multiple myeloma progression in high risk patients
RNA defects linked to multiple myeloma progression in high risk patients
UA targeting rhabdomyosarcoma, a rare paediatric cancer with few treatment options
UA targeting rhabdomyosarcoma, a rare paediatric cancer with few treatment options
ESMO 2018: Social vulnerability and medical skepticism top factors limiting adherence to cancer screening
ESMO 2018: Social vulnerability and medical skepticism top factors limiting adherence to cancer screening
Cancer spreading RNA now shows ability to suppress breast cancer metastasis
Cancer spreading RNA now shows ability to suppress breast cancer metastasis
ESMO 2018: Erlotinib improves progression-free survival in early mutated non-small cell lung cancer
ESMO 2018: Erlotinib improves progression-free survival in early mutated non-small cell lung cancer
ESMO 2018: Some patients with metastatic triple negative breast cancer live longer with immunotherapy
ESMO 2018: Some patients with metastatic triple negative breast cancer live longer with immunotherapy
<1...249250251252253...705>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top